XML 26 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Research and development expenses (Note 9) $ 9,499 $ 4,704
Marketing expenses 393 122
General and administrative expenses (Note 10) 4,655 2,278
Total operating expenses 14,547 7,104
Operating loss 14,547 7,104
Other (income) expense (14)
Change in fair value of derivative liability 798
Loss on equity issuance 1,925
Loss on settlement of liabilities 4,758
Finance expense (income), net (Note 7) 583 (7)
Loss for the year 22,597 7,097
Other comprehensive loss:    
Foreign currency translation adjustment (24) 1
Comprehensive loss for the year $ 22,573 $ 7,098
Basic loss per share $ 68.44 $ 34.18
Diluted loss per share $ 68.44 $ 34.18
Weighted average number of Common Stock outstanding used in computing basic net loss per share 330,171 207,603
Weighted average number of Common Stock outstanding used in computing diluted net loss per share 330,171 207,603